JPH0616667A - New production of pyrazolo(1,5-a)pyridine derivative - Google Patents
New production of pyrazolo(1,5-a)pyridine derivativeInfo
- Publication number
- JPH0616667A JPH0616667A JP17434892A JP17434892A JPH0616667A JP H0616667 A JPH0616667 A JP H0616667A JP 17434892 A JP17434892 A JP 17434892A JP 17434892 A JP17434892 A JP 17434892A JP H0616667 A JPH0616667 A JP H0616667A
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbon atoms
- formula
- pyrazolo
- pyridine derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は医薬品又は医薬品の原料
として有用なピラゾロ[1,5−a]ピリジン誘導体の
新規製造方法に関する。TECHNICAL FIELD The present invention relates to a novel method for producing a pyrazolo [1,5-a] pyridine derivative useful as a drug or a raw material for a drug.
【0002】[0002]
【従来の技術】ピラゾロ[1,5−a]ピリジン骨格を
有する化合物には薬理活性を示すものが数多くあり、例
えば、特公昭52−29318号、特公平4−2091
6号、特公平4−20917号公報に記載されている。2. Description of the Related Art Many compounds having a pyrazolo [1,5-a] pyridine skeleton exhibit pharmacological activity. For example, Japanese Patent Publication No. 52-29318 and Japanese Patent Publication No. 4-2091.
No. 6 and Japanese Patent Publication No. 4-20917.
【0003】従来、ピラゾロ[1,5−a]ピリジン骨
格の構築方法としては、1−アミノピリジニウム塩誘導
体にハロゲン化アシル誘導体を作用させるもの(J.O
rg.Chem.,33,3766(1968))、1
−アミノピリジニウム塩誘導体に酸無水物を、脱酸剤の
存在下に作用させるもの(特公昭52−29318号)
等が知られているが、この反応は加熱下の反応であって
着色等が起こる上に、満足のいく収率ではない。Conventionally, as a method for constructing a pyrazolo [1,5-a] pyridine skeleton, an acyl halide derivative is allowed to act on a 1-aminopyridinium salt derivative (J.O.
rg. Chem. , 33 , 3766 (1968)), 1
-Aminopyridinium salt derivative reacted with an acid anhydride in the presence of a deoxidizing agent (Japanese Patent Publication No. 52-29318)
However, this reaction is a reaction under heating, and coloring and the like occur, and the yield is not satisfactory.
【0004】より温和な条件で、より簡便で効率的なピ
ラゾロ[1,5−a]ピリジン誘導体合成法が医薬品合
成上からも望まれている。From the viewpoint of pharmaceutical synthesis, a more convenient and more efficient method for synthesizing a pyrazolo [1,5-a] pyridine derivative under milder conditions is desired.
【0005】[0005]
【発明が解決しようとする問題点】本発明の目的は、一
般式(1)で表されるピリジン誘導体から、より温和な
条件下で、効率的にピラゾロ[1,5−a]ピリジン誘
導体を製造する方法を提供することにある。DISCLOSURE OF THE INVENTION Problems to be Solved by the Invention An object of the present invention is to efficiently prepare a pyrazolo [1,5-a] pyridine derivative from a pyridine derivative represented by the general formula (1) under milder conditions. It is to provide a manufacturing method.
【0006】[0006]
【課題を解決するための手段】本発明者らは、上記課題
を解決するために鋭意研究を重ねた結果、一般式(1)Means for Solving the Problems As a result of intensive studies conducted by the present inventors to solve the above problems, the general formula (1)
【0007】[0007]
【化4】 [Chemical 4]
【0008】(式中、R1 は水素原子、炭素数1〜6の
低級アルキル基、ヒドロキシ基、炭素数1〜6の低級ア
ルコキシ基、炭素数1〜4の低級アルキル基の1から2
個で置換されていても良いアミノ基、カルボキシル基又
は炭素数2〜5の低級アルコキシカルボニル基を、R2
は水素原子、炭素数1〜4の低級アルキル基、又は炭素
数1〜4の低級アルコキシ基を示す)で表されるピリジ
ン誘導体から一般式(3)(Wherein R 1 is 1 to 2 of a hydrogen atom, a lower alkyl group having 1 to 6 carbon atoms, a hydroxy group, a lower alkoxy group having 1 to 6 carbon atoms, and a lower alkyl group having 1 to 4 carbon atoms.
An amino group which may be substituted by number, a carboxyl group or a lower alkoxycarbonyl group having 2 to 5 carbon atoms, R 2
Represents a hydrogen atom, a lower alkyl group having 1 to 4 carbon atoms, or a lower alkoxy group having 1 to 4 carbon atoms) to a general formula (3)
【0009】[0009]
【化5】 [Chemical 5]
【0010】(式中、R1 及びR2 は前記の通り)で表
されるピラゾロ[1,5−a]ピリジン誘導体を製造す
る際に、一般式(2)In the production of the pyrazolo [1,5-a] pyridine derivative represented by the formula (wherein R 1 and R 2 are as described above), the general formula (2)
【0011】[0011]
【化6】 [Chemical 6]
【0012】(式中、R3 はスルホン酸残基、置換基を
有していても良いフェニルスルホニル基、低級アルキル
スルホニル基、置換基を有していても良いフェニルカル
ボニル基又は低級アルカノイル基を示す)で表される化
合物を反応させることにより、温和な条件下で、効率的
にピラゾロ[1,5−a]ピリジン誘導体を製造できる
ことを見出し、発明を完成した。(In the formula, R 3 represents a sulfonic acid residue, a phenylsulfonyl group which may have a substituent, a lower alkylsulfonyl group, a phenylcarbonyl group which may have a substituent or a lower alkanoyl group. The present invention has been completed by finding that a pyrazolo [1,5-a] pyridine derivative can be efficiently produced under mild conditions by reacting a compound represented by the formula (1).
【0013】即ち、一般式(1)That is, the general formula (1)
【0014】[0014]
【化7】 [Chemical 7]
【0015】(式中、R1 及びR2 は前記の通り)で表
されるピリジン誘導体と一般式(2)(Wherein R 1 and R 2 are as described above) and the general formula (2)
【0016】[0016]
【化8】 [Chemical 8]
【0017】(式中、R3 は前記の通り)で表される化
合物とを、エーテル、1,2−ジクロルエタン、ベンゼ
ン、トルエン、ジクロルメタン等の反応に関与しない溶
媒中、−15℃〜室温、好ましくは−5〜10℃で反応
させることにより対応する一般式(3)(Wherein R 3 is as described above) and a compound not involved in the reaction such as ether, 1,2-dichloroethane, benzene, toluene and dichloromethane, at -15 ° C to room temperature, The corresponding general formula (3) is preferably obtained by reacting at −5 to 10 ° C.
【0018】[0018]
【化9】 [Chemical 9]
【0019】(式中、R1 及びR2 は前記の通り)で表
されるピラゾロ[1,5−a]ピリジン誘導体を高収率
で得ることができる。The pyrazolo [1,5-a] pyridine derivative represented by the formula (wherein R 1 and R 2 are as described above) can be obtained in high yield.
【0020】ここで、一般式(1)で表されるピリジン
誘導体は、例えば、Wolfe等の方法(J.Org.
Chem.,43,2286(1978))に従い、又
は準じて製造することができる。The pyridine derivative represented by the general formula (1) can be prepared by, for example, the method of Wolfe et al. (J. Org.
Chem. , 43 , 2286 (1978)) or in accordance therewith.
【0021】一般式(2)で表される化合物のR3 は、
置換基を有していても良いフェニルスルホニル基又は低
級アルキルスルホニル基が好ましく、特に1〜3個の炭
素数1〜3の低級アルキル基で置換されていても良いフ
ェニルスルホニル基が好ましい。R 3 of the compound represented by the general formula (2) is
A phenylsulfonyl group which may have a substituent or a lower alkylsulfonyl group is preferable, and a phenylsulfonyl group which may be substituted with 1 to 3 lower alkyl groups having 1 to 3 carbon atoms is particularly preferable.
【0022】ここで、一般式(2)で表される化合物の
うち、R3 が置換基を有していても良いフェニルスルホ
ニル基である化合物は、一般式(4)Here, among the compounds represented by the general formula (2), the compound in which R 3 is a phenylsulfonyl group which may have a substituent is represented by the general formula (4)
【0023】[0023]
【化10】 [Chemical 10]
【0024】(式中、R4は炭素数1〜4の低級アルキ
ル基を、R5は、炭素数1〜4の低級アルコキシ基を示
し、R6は置換基を有していても良いフェニルスルホニ
ル基を示す)で表される化合物を、ジオキサン、メタノ
ール等の反応に関与しない溶媒中、過塩素酸水溶液等と
反応させることにより製造できるが、この際、一般式
(2)の化合物は単離することなく一般式(1)で表さ
れる化合物との反応に用いることができる。(In the formula, R 4 represents a lower alkyl group having 1 to 4 carbon atoms, R 5 represents a lower alkoxy group having 1 to 4 carbon atoms, and R 6 represents phenyl which may have a substituent. It can be produced by reacting a compound represented by sulfonyl group) with an aqueous solution of perchloric acid or the like in a solvent such as dioxane or methanol that does not participate in the reaction. It can be used for the reaction with the compound represented by the general formula (1) without separation.
【0025】一般式(4)で表される化合物は、例え
ば、Tamura等の方法(J.Org.Chem.,
38,1239(1973))に従い、又は準じて製造
することができる。The compound represented by the general formula (4) can be obtained by, for example, the method of Tamura et al. (J. Org. Chem.,
38 , 1239 (1973)) or in accordance therewith.
【0026】得られた一般式(3)で表されるピラゾロ
[1,5−a]ピリジン誘導体は、例えば、酸無水物と
反応させ、要すれば更に処理することにより、特公昭5
2−29318号、特公平4−20916号、特公平4
−20917号公報に記載されている医薬品又は医薬品
の原料として有用な化合物に導くことができる。The obtained pyrazolo [1,5-a] pyridine derivative represented by the general formula (3) is reacted with, for example, an acid anhydride and, if necessary, further treated to obtain a desired compound.
No. 2-29318, Japanese Patent Publication No. 4-20916, Japanese Patent Publication No. 4
The compound described in JP-A-20917 can be used as a compound useful as a drug or a raw material for a drug.
【0027】[0027]
【実施例】以下に実施例を示し、本発明方法の有用性を
示すが、本発明は実施例に限定されるものではない。EXAMPLES The usefulness of the method of the present invention is shown below, but the present invention is not limited to the examples.
【0028】実施例1 2−イソプロピルピラゾロ[1,5−a]ピリジンの製
造 Example 1 Preparation of 2-isopropylpyrazolo [1,5-a] pyridine
【0029】[0029]
【化11】 [Chemical 11]
【0030】塩化メチレン(1.8ml)に3−メチル
−1−(2−ピリジル)−2−ブタノン(179.5m
g、1.10mM)を溶解し、0℃にて撹拌下、O−p
−トルエンスルホニルヒドロキシルアミンの塩化メチレ
ン溶液(6ml)(1.20mM相当)をゆっくり滴下
した。同温度で30分間撹拌した後、飽和重曹水、水、
飽和食塩水で順次、反応液を洗浄した。反応液を無水硫
酸ナトリウムで乾燥後、塩化メチレンを減圧下に留去
し、粗生成物を得た。粗生成物をシリカゲル薄層クロマ
トグラフィー(展開溶媒;n−ヘキサン:酢酸エチル=
3:1)にて精製し、目的物(143.2mg、収率8
1.3%)を得た。3-Methyl-1- (2-pyridyl) -2-butanone (179.5 m) in methylene chloride (1.8 ml).
g, 1.10 mM) and dissolved under stirring at 0 ° C.
A solution of toluenesulfonylhydroxylamine in methylene chloride (6 ml) (corresponding to 1.20 mM) was slowly added dropwise. After stirring for 30 minutes at the same temperature, saturated sodium bicarbonate water, water,
The reaction solution was washed successively with saturated saline. After the reaction solution was dried over anhydrous sodium sulfate, methylene chloride was distilled off under reduced pressure to obtain a crude product. The crude product was subjected to silica gel thin layer chromatography (developing solvent; n-hexane: ethyl acetate =
3: 1) and the desired product (143.2 mg, yield 8)
1.3%) was obtained.
【0031】NMR(CCl4、TMS標準) δPP
M: 8.30(1H,d、J=7Hz)、7.31(1H,
d、J=7Hz)、6.90(1H,t、J=7H
z)、6.49(1H,t、J=7Hz)、6.17
(1H,s)、3.12(1H,m,J=7Hz)、
1.33(6H,d,J=7Hz)実施例2 2−メチルピラゾロ[1,5−a]ピリジンの製造NMR (CCl 4 , TMS standard) δPP
M: 8.30 (1H, d, J = 7Hz), 7.31 (1H,
d, J = 7 Hz), 6.90 (1H, t, J = 7H)
z), 6.49 (1 H, t, J = 7 Hz), 6.17
(1H, s), 3.12 (1H, m, J = 7Hz),
1.33 (6H, d, J = 7Hz) Example 2 Preparation of 2 -methylpyrazolo [1,5-a] pyridine
【0032】[0032]
【化12】 [Chemical 12]
【0033】塩化メチレン(1.0ml)に1−(2−
ピリジル)−2−プロパノン(135.2mg、1.0
mM)を溶解し、0℃にて撹拌下、O−p−トルエンス
ルホニルヒドロキシルアミンの塩化メチレン溶液(3m
l)(1.0mM相当)をゆっくり滴下した。同温度で
30分間撹拌した後、飽和重曹水、水、飽和食塩水で順
次、反応液を洗浄した。反応液を無水硫酸ナトリウムで
乾燥後、塩化メチレンを減圧下に留去し、粗生成物を得
た。粗生成物をシリカゲル薄層クロマトグラフィー(展
開溶媒;n−ヘキサン:酢酸エチル=3:1)にて精製
し、目的物(105.9mg、収率80.1%)を得
た。1- (2- in methylene chloride (1.0 ml)
Pyridyl) -2-propanone (135.2 mg, 1.0
mM), and the solution of O-p-toluenesulfonylhydroxylamine in methylene chloride (3 m) was stirred at 0 ° C.
1) (corresponding to 1.0 mM) was slowly added dropwise. After stirring at the same temperature for 30 minutes, the reaction solution was washed successively with saturated aqueous sodium hydrogen carbonate, water and saturated brine. After the reaction solution was dried over anhydrous sodium sulfate, methylene chloride was distilled off under reduced pressure to obtain a crude product. The crude product was purified by silica gel thin layer chromatography (developing solvent; n-hexane: ethyl acetate = 3: 1) to obtain the desired product (105.9 mg, yield 80.1%).
【0034】NMR(CCl4、TMS標準) δPP
M: 8.30(1H,d、J=7Hz)、7.32(1H,
d、J=7Hz)、6.93(1H,t、J=7H
z)、6.51(1H,t、J=7Hz)、6.12
(1H,s)、2.41(3H,s)NMR (CCl 4 , TMS standard) δPP
M: 8.30 (1H, d, J = 7Hz), 7.32 (1H,
d, J = 7 Hz), 6.93 (1H, t, J = 7H)
z), 6.51 (1H, t, J = 7Hz), 6.12
(1H, s) 2.41 (3H, s)
【0035】[0035]
【発明の効果】以上のように、本発明方法によればピリ
ジン誘導体から、温和な条件下に高収率でピラゾロ
[1,5−a]ピリジン誘導体を製造することが可能で
ある。As described above, according to the method of the present invention, a pyrazolo [1,5-a] pyridine derivative can be produced from a pyridine derivative in a high yield under mild conditions.
Claims (1)
基、ヒドロキシ基、炭素数1〜6の低級アルコキシ基、
炭素数1〜4の低級アルキル基の1から2個で置換され
ていても良いアミノ基、カルボキシル基又は炭素数2〜
5の低級アルコキシカルボニル基を、R2 は水素原子、
炭素数1〜4の低級アルキル基、又は炭素数1〜4の低
級アルコキシ基を示す)で表されるピリジン誘導体に一
般式(2) 【化2】 (式中、R3 はスルホン酸残基、置換基を有していても
良いフェニルスルホニル基、低級アルキルスルホニル
基、置換基を有していても良いフェニルカルボニル基又
は低級アルカノイル基を示す)で表される化合物を反応
させることを特徴とする一般式(3) 【化3】 (式中、R1 及びR2 は前記の通り)で表されるピラゾ
ロ[1,5−a]ピリジン誘導体の製造方法。1. A compound represented by the general formula (1): (In the formula, R 1 is a hydrogen atom, a lower alkyl group having 1 to 6 carbon atoms, a hydroxy group, a lower alkoxy group having 1 to 6 carbon atoms,
An amino group which may be substituted with 1 to 2 lower alkyl groups having 1 to 4 carbon atoms, a carboxyl group or 2 to 2 carbon atoms
5 is a lower alkoxycarbonyl group, R 2 is a hydrogen atom,
A pyridine derivative represented by a lower alkyl group having 1 to 4 carbon atoms or a lower alkoxy group having 1 to 4 carbon atoms is represented by the general formula (2): (In the formula, R 3 represents a sulfonic acid residue, an optionally substituted phenylsulfonyl group, a lower alkylsulfonyl group, an optionally substituted phenylcarbonyl group or a lower alkanoyl group) A compound represented by the general formula (3): (In the formula, R 1 and R 2 are as described above) A method for producing a pyrazolo [1,5-a] pyridine derivative.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17434892A JPH0616667A (en) | 1992-07-01 | 1992-07-01 | New production of pyrazolo(1,5-a)pyridine derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17434892A JPH0616667A (en) | 1992-07-01 | 1992-07-01 | New production of pyrazolo(1,5-a)pyridine derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0616667A true JPH0616667A (en) | 1994-01-25 |
Family
ID=15977075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP17434892A Pending JPH0616667A (en) | 1992-07-01 | 1992-07-01 | New production of pyrazolo(1,5-a)pyridine derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0616667A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6011052A (en) * | 1996-04-30 | 2000-01-04 | Warner-Lambert Company | Pyrazolone derivatives as MCP-1 antagonists |
US7285666B2 (en) * | 2001-04-27 | 2007-10-23 | Eisai R&D Management Co., Ltd. | Pyrazolo[1,5-a] pyridines and medicines containing the same |
-
1992
- 1992-07-01 JP JP17434892A patent/JPH0616667A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6011052A (en) * | 1996-04-30 | 2000-01-04 | Warner-Lambert Company | Pyrazolone derivatives as MCP-1 antagonists |
US7285666B2 (en) * | 2001-04-27 | 2007-10-23 | Eisai R&D Management Co., Ltd. | Pyrazolo[1,5-a] pyridines and medicines containing the same |
US7625925B2 (en) | 2001-04-27 | 2009-12-01 | Eisai R&D Management Co., Ltd | Pyrazolo[1,5-a]pyridines and medicines containing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3822254A (en) | Synthesis of 25-hydroxycholesterol | |
FR2527615A1 (en) | PROCESS FOR PREPARING 26,26,26,27,27,27-HEXAFLUORO-1A, 25-DIHYDROXYCHOLESTEROL | |
EP0080381B1 (en) | Homobrassinolide, and its production and use | |
SU910118A3 (en) | Process for producing n -glucofuranozid-6-yl-n -nitrosocarbamide | |
JPS6360031B2 (en) | ||
JPH0616667A (en) | New production of pyrazolo(1,5-a)pyridine derivative | |
JPH023797B2 (en) | ||
JPH0364510B2 (en) | ||
EP1688409B1 (en) | Vitamin d-derived monohalogenovinyl compounds | |
JP2872468B2 (en) | Isocarbacycline derivatives, their production and photoaffinity labeling | |
JPS6152839B2 (en) | ||
HU182583B (en) | Process for preparing prostacyclin and analogues thereof | |
JPS6039278B2 (en) | steroid derivatives | |
JP2980992B2 (en) | Method for producing 6-halogeno-2-oxapregna-4,6-dien-3-one compound | |
JPH01100147A (en) | Optically active malonic acid ester derivative | |
JP2504934B2 (en) | 1,6,7-Triacylforskolin derivative | |
JPH09249691A (en) | Production of 25-hydroxycholesterols and synthetic intermediate therefor | |
JPS5841878A (en) | Benzodiazepin derivative, its preparation and anticancer agent containing the same | |
JPH0529237B2 (en) | ||
JPH0296592A (en) | 20-methyl-21-hydroxypregnane derivative | |
JPH01100195A (en) | Production of 1alpha,24-dihydroxycholesterols | |
JPH0362716B2 (en) | ||
FR2664277A1 (en) | Sinefungin derivatives, their preparation and their application in therapeutics | |
JPS63156797A (en) | 14-(omega,omega,omega-trifluoroalkyl)-4-demethoxydaunorubicin derivative | |
JPS61100542A (en) | Novel 4-hydroxy-2-cyclopentenone compound and its preparation |